October 4, 2023 4:08 pm

Biden Pick for FDA Chief Holds Millions in Big Pharma Investments

Facebook
Twitter
LinkedIn
Pinterest
WhatsApp
Telegram

URGENT: JUST 11 DAYS REMAIN TO HELP SAVE INDEPENDENT MEDIA & ANR, TO ENSURE WE ARE FULLY FUNDED FOR NEXT MONTH,SO LET'S CUT THE BS & GET TO THE POINT - WE WILL BE FORCED LAY OFF STAFF & REDUCE OPERATIONS UNLESS WE ARE FULLY FUNDED WITHIN THE NEXT 2 WEEKS - Sadly, less than 0.5% of readers currently donate or subscribe to us But YOU can easily change that. Imagine the impact we'd make if 3 in 10 readers supported us today. To start with we’d remove this annoying banner as we could fight for a full year...

Biden Pick for FDA Chief Holds Millions in Big Pharma Investments

By Brett Wilkins

Sen. Bernie Sanders last week said he would oppose President Joe Biden’s nomination of Dr. Robert Califf to lead the U.S. Food and Drug Administration (FDA) for the second time, citing the cardiologist’s multimillion-dollar ties to Big Pharma.

Califf — who served as FDA commissioner during the final 11 months of the Obama administration — mostly skated through a congenial Senate confirmation hearing Tuesday.

According to STAT, his only stumble occurred when he was pressed about the FDA’s role and failings in the opioid crisis.

The Associated Press reports Senate Health, Education, Labor and Pensions Committee Chair Patty Murray (D-Wash.) and the ranking Republican member, Sen. Richard Burr of North Carolina, both said they would vote to confirm Califf.

Sanders (I-Vt.), however, reprised his 2015 confirmation grilling of Califf over his lucrative ties to Big Pharma.

“One of the major reasons the pharmaceutical industry, among many others, is so powerful is its close relationship with the FDA and other regulators in Washington,” the democratic socialist, who twice ran for president on a Medicare for All platform, said during the hearing.

“What kind of comfort can you give to the American people when you have been so closely tied to the pharmaceutical industry yourself?”

Califf — who has made millions of dollars as a consultant for more than a dozen pharmaceutical corporations and who holds millions more in Big Pharma investments — replied that he was “totally with” Sanders, agreeing that “the price of pharmaceuticals is way too high in this country.”

Sanders said he would once again vote to reject Califf’s nomination.

“At a time when the American people pay the highest prices in the world for prescription drugs and as drug companies continue to be the most powerful special interest in Washington, we need leadership at the FDA that is finally willing to stand up to the greed and power of the pharmaceutical industry,” Sanders said in a statement.

“Not only have the drug companies spent over $4.5 billion on lobbying and hundreds of millions of dollars in campaign contributions over the past 20 years, they also have created a revolving door between the FDA and the industry,” he continued. “Shockingly, nine out of the last 10 FDA commissioners went on to work for the pharmaceutical industry or to serve on a prescription drug company’s board of directors.”

“Unfortunately, Dr. Califf is not the exception to that rule,” Sanders said. “After leaving the FDA in 2017, he received consulting fees from Merck, Biogen, and Eli Lilly. According to his financial disclosure form, he owns up to $8 million in the stocks of major drug companies.”

“That is exactly the close relationship Big Pharma has exploited to regulate the FDA, instead of the FDA regulating them,” he added. “The Covid-19 pandemic has made clearer than ever the choice between pharmaceutical profits and the health of our people. In this critical moment, Dr. Califf is not the leader Americans need at the FDA and I will oppose his nomination.”

Sixty-nine current senators voted for Califf’s previous nomination.

In addition to Sanders, at least two other members of the Democratic caucus oppose his appointment: Sens. Richard Blumenthal (D-Ct.), who cites his industry ties, and Joe Manchin (D-W.Va.), who last month said that the nomination “makes no sense as the opioid epidemic continues to wreak havoc on families across this country with no end in sight.”

Opinion pieces don’t necessarily reflect the position of our news site but of our Opinion writers.

Support the ANR from as little as $8 – it only takes a minute. If you can, please consider supporting us with a regular amount each month. Thank you.

Related News

Subscribe for free to our ANR news emails and access 2 free ebooks plus Reports to share with family and friends about Covid fraud and the danger of the vaccines.

Australian National Review is Australia’s first real free and independent press, one with no editorial control by the elite, but a publication that can generate critical thinkers and critical debate and hold those spreading mistruths and deliberate propaganda in mainstream media to account.

News with a difference that will be educational, compelling and create a platform for political and social change in this country and address the real issues facing this country and the world.

Watch Full Documentary

URGENT: JUST 3 DAYS REMAIN TO HELP SAVE INDEPENDENT MEDIA & ANR, SO LET'S CUT THE BS & GET TO THE POINT - WE WILL BE FORCED TO LAY OFF STAFF & REDUCE OPERATIONS UNLESS WE ARE FULLY FUNDED WITHIN THE NEXT 2 WEEKS

Sadly, less than 0.5% of readers currently donate or subscribe to us But YOU can easily change that. Imagine the impact we'd make if 3 in 10 readers supported us today. To start with we’d remove this annoying banner as we could fight for a full year...

Get access to TruthMed- how to save your family and friends that have been vaxx with vaccine detox, & how the Unvaxxed can prevent spike protein infection from the jabbed.

Free with ANR Subscription from $8

Download the Full PDF - THE COVID-19 FRAUD & WAR ON HUMANITY